-+ 0.00%
-+ 0.00%
-+ 0.00%

TRAWS PHARMA COMPLETES ENROLLMENT OF RATUTRELVIR CLINICAL STUDY IN PAXLOVID®-ELIGIBLE AND INELIGIBLE COVID-19 PATIENTS; ANNOUNCES PLANS FOR ADDED INDICATION FOR TIVOXAVIR MARBOXIL AS A PROPHYLACTIC TREATMENT FOR SEASONAL INFLUENZA

Reuters·01/26/2026 13:30:01

Please log in to view news